Filing Details
- Accession Number:
- 0000899243-19-008814
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-22 18:01:50
- Reporting Period:
- 2019-03-20
- Accepted Time:
- 2019-03-22 18:01:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1066040 | Jr E Francis Odonnell | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-20 | 62,500 | $0.00 | 583,687 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 62,500 | $0.00 | 646,187 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 15,000 | $0.00 | 661,187 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 15,000 | $0.00 | 676,187 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 9,757 | $0.00 | 685,944 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-03-21 | 71,690 | $5.21 | 614,254 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2019-03-20 | 62,500 | $0.00 | 62,500 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2019-03-20 | 62,500 | $0.00 | 62,500 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2019-03-20 | 15,000 | $0.00 | 15,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2019-03-20 | 15,000 | $0.00 | 15,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2019-03-20 | 9,757 | $0.00 | 9,757 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 62,500 | 2020-03-19 | No | 4 | M | Direct | |
| 0 | 2020-03-19 | No | 4 | A | Direct | |
| 30,000 | 2021-03-19 | No | 4 | M | Direct | |
| 0 | 2021-03-19 | No | 4 | A | Direct | |
| 0 | 2019-03-20 | No | 4 | A | Direct |
Footnotes
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures.
- The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan.
- On March 21, 2019, the Reporting Person sold an aggregate of 71,690 shares of the Common Stock at a weighted average price of $5.21 per share. The highest sale price for the Common Stock was $5.33 per share and the lowest sale price was $5.04 per share.
- The shares of Common Stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in these footnotes.
Billionaire Hedge Funds
